NEW YORK, Sept. 05, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Associated Capital Group, Inc. (“AC”) (OTCQX: ACGP) has voluntarily delisted from the New York Stock Exchange and has qualified to trade on the OTCQX® Best Market. Associated Capital Group, Inc. begins trading today on OTCQX under the symbol “ACGP”. U.S. investors can find current financial disclosure and Real-Time Level 2 quot ...

-- The 2025 DREAMS Grant Program awards $50,000 each to two non-profit organizations working to advance equity, accessibility and inclusion for those living with Duchenne in the U.S., EU or U.K. -- -- Announced in advance of World Duchenne Awareness Day on September 7, grants are designed to fund projects supporting the Duchene community on a global scale -- BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the recipients of its third annual DREAMS Grant Pr ...

Core Viewpoint - Koryx Copper Inc. plans to change its corporate domicile from British Columbia, Canada to Luxembourg, aiming to better align its legal structure with operational and financing strategies, while continuing to support shareholder interests [1][2]. Group 1: Corporate Change - The company intends to change its name to Koryx Copper S.A. and expects the change to be effective on October 16, 2025, pending shareholder and stock exchange approval [1][3]. - The Continuation will not disrupt the trading of the company's shares on the TSX Venture Exchange and Namibian Securities Exchange [1][4]. - A special meeting of shareholders is scheduled for October 15, 2025, to discuss the Continuation and related matters [4]. Group 2: Strategic Rationale - The Continuation is expected to provide expanded strategic flexibility and enhanced access to international markets, creating a favorable environment for future investments [2]. - The move aligns the company's legal and corporate structure with its operational footprint and financing strategy [2]. Group 3: Company Overview - Koryx Copper Inc. focuses on advancing the Haib Copper Project in Namibia, which is a significant copper/molybdenum porphyry deposit [6]. - The Haib project has a current mineral resource of 414 million tonnes at 0.35% copper in the Indicated category and 345 million tonnes at 0.33% copper in the Inferred category [7]. - The mineralization at Haib is characterized as typical of a porphyry copper deposit, with significant historical exploration and development [8].

MONTREAL, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Supremex Inc. (“Supremex” or the “Company”) (TSX: SXP), a leading North American manufacturer and marketer of envelopes and a growing provider of paper-based packaging solutions, announced today the appointment of Normand Macaulay as Chief Financial Officer and Corporate Secretary, effective September 15, 2025. Mr. Macaulay is a highly accomplished and talented financial executive with more than 20 years of leadership experience in finance and operations with lar ...

Group 1 - Cartier Silver Corporation is proceeding with a non-brokered private placement for proceeds of up to $1.5 million [1][2] - The private placement will consist of up to 12,000,000 units at a price of $0.125 per unit, with each unit including one common share and one half of a common share purchase warrant [2] - Each warrant will allow the holder to purchase one common share at a price of $0.20 per share for a term of 36 months following the closing of the private placement [2] Group 2 - The net proceeds from the private placement will be used to finance exploration at the Chorrillos Project in Bolivia and for working capital purposes [3] - The private placement is subject to all required regulatory approvals, and all securities issued will be subject to a four-month hold period [3] Group 3 - Cartier Silver is focused on discovering and developing silver property assets, including the Chorrillos Project, and also holds significant iron ore resources and gold property [5]

Core Insights - ABM reported a strong fiscal third quarter with a revenue increase of 6.2% year-over-year, reaching $2.2 billion, driven by 5.0% organic growth and 1.2% from acquisitions [3][6][34] - The company secured over $1.5 billion in new bookings, marking a 15% increase year-over-year, indicating a robust pipeline for future growth [2][3] - Net income rose significantly to $41.8 million, or $0.67 per diluted share, compared to $4.7 million, or $0.07 per diluted share in the prior year [4][6][34] Financial Performance - Adjusted net income was $51.7 million, or $0.82 per diluted share, slightly down from $53.6 million, or $0.84 per diluted share in the previous year [5][6] - Adjusted EBITDA increased to $125.8 million, maintaining a margin of 5.9% [5][6] - Operating cash flow surged by 120.1% to $175.0 million, while free cash flow increased by 134.3% to $150.2 million [6][8] Segment Performance - Technical Solutions and Aviation segments led revenue growth, with increases of 19% and 9% respectively [3][34] - Manufacturing & Distribution grew by 8% due to new client wins, while Business & Industry and Education segments both saw a 3% increase [3][34] - The company noted slower recovery in some commercial office markets, particularly in select West Coast, Midwest, and Mid-Atlantic areas [2][3] Strategic Initiatives - ABM launched a restructuring program aimed at improving operational efficiency, expected to generate approximately $35 million in annualized cost savings [9][10] - The company is actively investing in AI capabilities and client-facing resources to drive higher growth and improved margins over time [2][9] - Share repurchase activities included the repurchase of approximately 1.5 million shares year-to-date, reflecting confidence in the company's strategic direction [12][13] Outlook - For the full fiscal year, ABM expects adjusted EPS to be toward the low end of the outlook range of $3.65 to $3.80 [15] - The company anticipates improved adjusted EPS and margin results in the fourth quarter, driven by restructuring benefits and strong performance in the ATS segment [2][15]

Core Viewpoint - American National Group Inc. will redeem all outstanding shares of its 6.625% Fixed-Rate Reset Non-Cumulative Preferred Stock, Series B, on October 6, 2025, affecting 12,000 shares and corresponding depositary shares [1][2]. Group 1: Redemption Details - The redemption price for the Depositary Shares will be $25.00 per share, plus any declared but unpaid dividends and a portion of the quarterly dividend for the current period [2]. - The redemption will be executed through The Depository Trust Company (DTC), with Computershare Inc. acting as the redemption agent [3]. - Upon redemption, all rights related to the Series B Preferred Stock and Depositary Shares will cease, except for the right to receive the redemption price [4]. Group 2: Delisting and Deregistration - Following the redemption, the Company plans to delist the Depositary Shares from the New York Stock Exchange (NYSE) and deregister them with the Securities and Exchange Commission (SEC) [5]. - The Company will file a notification of removal from listing and registration on Form 25 with the SEC, and intends to file a certification on Form 15 for termination of registration [5]. Group 3: Company Overview - American National Group Inc. provides a wide range of insurance products and services through its subsidiaries, operating across all 50 U.S. states [6].

Company Overview - Akari Therapeutics is an oncology biotechnology company focused on developing next-generation spliceosome payload antibody drug conjugates (ADCs) [4] - The company utilizes an innovative ADC discovery platform to generate and optimize ADC candidates for various targets [4] Lead Product Candidate - Akari's lead candidate, AKTX-101, targets the Trop2 receptor on cancer cells and employs a proprietary linker to deliver a novel PH1 payload directly into tumors [4] - PH1 is a spliceosome modulator designed to disrupt RNA splicing within cancer cells, leading to cancer cell death and activation of immune cells [4] - Preclinical studies indicate that AKTX-101 has significant activity and prolonged survival compared to traditional ADCs, and it shows potential synergy with checkpoint inhibitors [4] Upcoming Events - Abizer Gaslightwala, President and CEO of Akari Therapeutics, will present at the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10, 2025 [1] - Management will also be available for in-person one-on-one meetings with qualified investors during the conference [2] - A video webcast of the presentation will be available on-demand starting September 5, 2025, and will be archived for 90 days [3]

Core Viewpoint - Hyperscale Data, Inc. has announced that its subsidiary Sentinum, Inc. has accumulated Bitcoin holdings equivalent to approximately 8.1% of the company's current market capitalization, all earned through mining operations without purchasing from the open market [1][2]. Group 1: Bitcoin Accumulation Strategy - The company's strategy involves mining and retaining all Bitcoin produced until the holdings equal 100% of its market capitalization, reinforcing the belief that Bitcoin serves as a long-term store of value [2][3]. - As of now, the company is nearing 10% of its market capitalization in Bitcoin holdings through mining, marking a significant milestone in its strategy [3]. Group 2: Business Operations and Growth - The Bitcoin accumulation strategy is positioned as a complement to the company's core business, which includes expanding its AI data center operations in Michigan and planned growth in Montana [3]. - The company aims to combine digital asset reserves with advanced AI computing facilities to strengthen its balance sheet and establish itself as a leader in the convergence of AI and blockchain technologies [3]. Group 3: Future Plans and Divestiture - Hyperscale Data expects to divest Ault Capital Group, Inc. in the first quarter of 2026, transitioning to a focus on data center operations and digital asset holdings [6]. - The divestiture will involve an exchange of Series F Preferred Stock for shares of ACG, allowing stockholders to become shareholders of ACG upon completion [7].

Group 1 - The Extraordinary General Meeting of Nykredit Realkredit A/S was held on 5 September 2025 [1] - Shareholders approved the Board of Directors' proposal for a revised Remuneration Policy [1]